Imbrium Therapeutics
- Biotech or pharma, therapeutic R&D
Imbrium Therapeutics is a privately held clinical stage biopharmaceutical company dedicated to advancing medical science by developing new non-opioid therapies to treat pain, cancer, genitourinary disorders, and disorders of the central nervous system. A Company Presentation is scheduled for Wednesday, June 18 at 9:15 AM in Room 153B.